These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 28342790)

  • 1. Lipocalin-2 and iron trafficking in the tumor microenvironment.
    Jung M; Mertens C; Bauer R; Rehwald C; Brüne B
    Pharmacol Res; 2017 Jun; 120():146-156. PubMed ID: 28342790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Iron as a Central Player and Promising Target in Cancer Progression.
    Jung M; Mertens C; Tomat E; Brüne B
    Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30641920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Iron and cancer: more ore to be mined.
    Torti SV; Torti FM
    Nat Rev Cancer; 2013 May; 13(5):342-55. PubMed ID: 23594855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macrophage iron homeostasis and polarization in the context of cancer.
    Jung M; Mertens C; Brüne B
    Immunobiology; 2015 Feb; 220(2):295-304. PubMed ID: 25260218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracellular Iron Chelation Modulates the Macrophage Iron Phenotype with Consequences on Tumor Progression.
    Mertens C; Akam EA; Rehwald C; Brüne B; Tomat E; Jung M
    PLoS One; 2016; 11(11):e0166164. PubMed ID: 27806101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iron and Its Role in Cancer Defense: A Double-Edged Sword.
    Thévenod F
    Met Ions Life Sci; 2018 Feb; 18():. PubMed ID: 29394034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Iron Curtain: Macrophages at the Interface of Systemic and Microenvironmental Iron Metabolism and Immune Response in Cancer.
    DeRosa A; Leftin A
    Front Immunol; 2021; 12():614294. PubMed ID: 33986740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Roles of NGAL and MMP-9 in the tumor microenvironment and sensitivity to targeted therapy.
    Candido S; Abrams SL; Steelman LS; Lertpiriyapong K; Fitzgerald TL; Martelli AM; Cocco L; Montalto G; Cervello M; Polesel J; Libra M; McCubrey JA
    Biochim Biophys Acta; 2016 Mar; 1863(3):438-448. PubMed ID: 26278055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iron Handling in Tumor-Associated Macrophages-Is There a New Role for Lipocalin-2?
    Jung M; Weigert A; Mertens C; Rehwald C; Brüne B
    Front Immunol; 2017; 8():1171. PubMed ID: 28979267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Iron Metabolism in Cancer.
    Wang Y; Yu L; Ding J; Chen Y
    Int J Mol Sci; 2018 Dec; 20(1):. PubMed ID: 30591630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel chelators for cancer treatment: where are we now?
    Merlot AM; Kalinowski DS; Richardson DR
    Antioxid Redox Signal; 2013 Mar; 18(8):973-1006. PubMed ID: 22424293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The medicinal chemistry of novel iron chelators for the treatment of cancer.
    Kovacevic Z; Kalinowski DS; Lovejoy DB; Yu Y; Suryo Rahmanto Y; Sharpe PC; Bernhardt PV; Richardson DR
    Curr Top Med Chem; 2011; 11(5):483-99. PubMed ID: 21192781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microenvironment acidity as a major determinant of tumor chemoresistance: Proton pump inhibitors (PPIs) as a novel therapeutic approach.
    Taylor S; Spugnini EP; Assaraf YG; Azzarito T; Rauch C; Fais S
    Drug Resist Updat; 2015 Nov; 23():69-78. PubMed ID: 26341193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enterobactin, an iron chelating bacterial siderophore, arrests cancer cell proliferation.
    Saha P; Yeoh BS; Xiao X; Golonka RM; Kumarasamy S; Vijay-Kumar M
    Biochem Pharmacol; 2019 Oct; 168():71-81. PubMed ID: 31228465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting cancer by binding iron: Dissecting cellular signaling pathways.
    Lui GY; Kovacevic Z; Richardson V; Merlot AM; Kalinowski DS; Richardson DR
    Oncotarget; 2015 Aug; 6(22):18748-79. PubMed ID: 26125440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor microenvironment on the move and the Aselli connection.
    Rodvold JJ; Zanetti M
    Sci Signal; 2016 Jun; 9(434):fs13. PubMed ID: 27353363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A promising new approach to cancer therapy: Targeting iron metabolism in cancer stem cells.
    El Hout M; Dos Santos L; Hamaï A; Mehrpour M
    Semin Cancer Biol; 2018 Dec; 53():125-138. PubMed ID: 30071257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Iron Metabolism in the Tumor Microenvironment: Contributions of Innate Immune Cells.
    Liang W; Ferrara N
    Front Immunol; 2020; 11():626812. PubMed ID: 33679721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Promising New Anti-Cancer Strategy: Iron Chelators Targeting CSCs.
    Chen Y; Ohara T; Xing B; Qi J; Noma K; Matsukawa A
    Acta Med Okayama; 2020 Feb; 74(1):1-6. PubMed ID: 32099242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent advances in cancer treatment by iron chelators.
    Corcé V; Gouin SG; Renaud S; Gaboriau F; Deniaud D
    Bioorg Med Chem Lett; 2016 Jan; 26(2):251-256. PubMed ID: 26684852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.